Hepatitis C virus seroconversion rate in established blood donors
✍ Scribed by H. I. Atrah; F. Hutchinson; D. Gough; F. A. Ala; M. M. Ahmed
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 612 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The results of hepatitis C virus (HCV) antibody test of 237, 813 blood donations collected from 143, 815 donors by the West Midlands Blood Transfusion Centre in 1993 were analyzed retrospectively in order to determine the seroconversion rate among established previously anti‐HCV negative donors. Three hundred sixteen (0.22%; 1 in 455) donors were positive by the enzyme linked immunosorbent assay (ELISA) screening test and 34 (0.024%; 1 in 4, 230) donors were positive by ELISA and the Recombinant Immuno Blot Assay (RIBA). Three donors previously negative for HCV antibody reacted positively by both tests. The annual seroconversion rate was calculated as one in 35, 937 donors. This figure argues against limitation of HCV antibody screening to new blood donors. A further 45 donors negative on previous screening reacted positively by ELISA and were indeterminate by RIBA. Unexpectedly, lapsed blood donors first tested for HCV antibody in 1993 had high positive reaction rates by ELSA and RIBA, which was significantly (P < 0.001) higher than those of new donors. RIBA‐positive reaction rate among ELISA‐positive donors was significantly higher amongst males than females (P < 0.0011. © 1995 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Of 103,203 donations collected in Scotland and Northern Ireland over a 3‐month period and screened for HCV antibody by Ortho or Abbott second‐generation ELISAs, 340 were found repeatedly reactive. Supplementary testing with RIBA‐2 resulted in 77 being classified as positive, 130 as inde
Among 248 asymptomatic blood donors positive for anti-widespread in the blood donor population, that hepatitis C accounted for more than 90% of transfusion-transmitted body to hepatitis C virus (anti-HCV) enrolled in a long-term prospective study, 86% had chronic HCV infection and 14% hepatitis, and
Sera from 62 hepatitis C virus (HCV)-infected Swedish blood donors were tested by a nested polymerase chain reaction using primers targeting the 5Ј-noncoding region of the GB virus-C/ hepatitis G (GBV-C/HGV) genome and an enzyme-linked immunosorbent assay that detects antibodies to the envelope prot
RNAs of GB virus C (GBV-C) and hepatitis C virus (HCV) were sought by reverse-transcription polymerase chain reaction with nested primers deduced from the 5Ј untranslated region: 79 patients on maintenance hemodialysis, 205 commercial blood donors, and 205 voluntary donors in Beijing were studied. G